• Thumbnail for MTOR inhibitors
    mTOR inhibitors are a class of drugs used to treat several human diseases, including cancer, autoimmune diseases, and neurodegeneration. They function...
    57 KB (6,281 words) - 12:56, 6 November 2024
  • Thumbnail for MTOR
    is encoded by the MTOR gene. mTOR is a member of the phosphatidylinositol 3-kinase-related kinase family of protein kinases. mTOR links with other proteins...
    119 KB (12,661 words) - 15:12, 8 November 2024
  • Thumbnail for PI3K/AKT/mTOR pathway
    The PI3K/AKT/mTOR pathway is an intracellular signaling pathway important in regulating the cell cycle. Therefore, it is directly related to cellular quiescence...
    36 KB (4,322 words) - 11:55, 11 August 2024
  • Thumbnail for MTORC1
    MTORC1 (redirect from MTOR Complex 1)
    rapamycin. These drugs are considered the first generation inhibitors of mTOR. These other inhibitors include everolimus and temsirolimus. Compared with the...
    69 KB (7,807 words) - 19:19, 19 September 2024
  • Thumbnail for Sirolimus
    Sirolimus was shown to inhibit the progression of dermal Kaposi's sarcoma in patients with renal transplants. Other mTOR inhibitors, such as temsirolimus...
    70 KB (7,051 words) - 03:41, 9 November 2024
  • Thumbnail for Phosphoinositide 3-kinase inhibitor
    3-kinase inhibitors (PI3K inhibitors) are a class of medical drugs that are mainly used to treat advanced cancers. They function by inhibiting one or more...
    45 KB (5,359 words) - 22:07, 19 July 2024
  • Lattanzi, Giovanna (November 2016). "Potential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria-related disorders". British Journal...
    14 KB (1,439 words) - 13:57, 18 November 2024
  • Thumbnail for Immunosuppressive drug
    Immunosuppression BK virus Behcet's Disease Discovery and development of mTOR inhibitors Treatment methods for preventing organ rejection Jennings DL (2020)...
    29 KB (3,378 words) - 02:54, 25 September 2024
  • Thumbnail for Farnesyltransferase inhibitor
    molecules are called FTIs (or farnesyl-transferase inhibitors). As with mTOR inhibitors, many companies developed them to treat cancers, where they were unsuccessful...
    12 KB (1,079 words) - 17:42, 26 May 2021
  • Thumbnail for XL-388
    XL-388 (category Enzyme inhibitors)
    and has also been used to demonstrate a potential application for mTOR inhibitors in the treatment of neuropathic pain. Takeuchi CS, Kim BG, Blazey CM...
    4 KB (326 words) - 23:30, 5 August 2024
  • Thumbnail for Protein kinase B
    Akt/PKB signaling pathway Discovery and development of mTOR inhibitors PI3K/AKT/mTOR pathway Akt inhibitor PTEN PDB: 3MV5​; Freeman-Cook KD, Autry C, Borzillo...
    35 KB (3,831 words) - 18:08, 20 August 2024
  • Thumbnail for Torin-1
    Torin-1 (category Enzyme inhibitors)
    which was one of the first non-rapalog derived inhibitors of the mechanistic target of rapamycin (mTOR) subtypes mTORC1 and mTORC2. In animal studies...
    7 KB (642 words) - 12:03, 15 November 2024
  • Thumbnail for Gedatolisib
    Gedatolisib (category Phosphoinositide 3-kinase inhibitors)
    PMID 29078414. Tian T, Li X, Zhang J (February 2019). "mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy". International Journal...
    9 KB (855 words) - 05:13, 9 September 2024
  • Akt/PKB signaling pathway Discovery and development of mTOR inhibitors PI3K/AKT/mTOR pathway Akt inhibitor This disambiguation page lists articles associated...
    456 bytes (71 words) - 20:28, 13 July 2021
  • growth, proliferation, and survival. mTOR inhibitors lead to cell cycle arrest in the G1 phase and also inhibits tumor angiogenesis by reducing synthesis...
    20 KB (2,453 words) - 10:36, 1 June 2024
  • Thumbnail for Transplant rejection
    a calcineurin inhibitor and an anti-proliferative agent. Where calcineurin inhibitors or steroids are contraindicated, mTOR inhibitors are used. Immunosuppressive...
    29 KB (3,272 words) - 23:54, 28 May 2024
  • Thumbnail for Sapanisertib
    (Isoquinolin-4-yl)-1H-Pyrazolo[3,4-d]Pyrimidine Derivatives as Dual PI3-K/mTOR Inhibitors". Current Drug Discovery Technologies. 16 (3): 297–306. doi:10...
    5 KB (323 words) - 09:39, 24 June 2024
  • Lattanzi, Giovanna (November 2016). "Potential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria-related disorders". British Journal...
    74 KB (8,734 words) - 13:28, 2 November 2024
  • malignant tumors. Thus angiogenesis inhibitors have been closely studied for possible cancer treatment. Angiogenesis inhibitors were once thought to have potential...
    33 KB (3,229 words) - 19:54, 7 July 2024
  • Thumbnail for Lymphangioleiomyomatosis
    mTOR inhibitors are effective at shrinking the size of lymphangioleiomyomatosis, and can lead to total resolution. Sirolimus is an mTOR inhibitor that...
    100 KB (11,094 words) - 10:45, 2 November 2024
  • Thumbnail for Immunosuppression
    immunodeficiency of T-cells. Immunosuppressive drug Discovery and development of mTOR inhibitors BK virus Interleukin-2 immunotherapy B cell deficiency T cell deficiency...
    10 KB (938 words) - 16:41, 3 December 2023
  • Thumbnail for Voxtalisib
    Voxtalisib (category Phosphoinositide 3-kinase inhibitors)
    which acts as a dual inhibitor of the kinase enzymes phosphatidylinositol 3-kinase (PI3K) and mechanistic target of rapamycin (mTOR). It is in clinical...
    4 KB (280 words) - 02:28, 8 May 2023
  • Thumbnail for Papillary renal cell carcinoma
    medications, tyrosine kinase inhibitors (TKIs) and mammalian target of rapamycin (mTOR) inhibitors are effective in inhibiting angiogenesis, blocking growth...
    38 KB (3,726 words) - 20:03, 27 October 2023
  • Thumbnail for GSK-3
    GSK-3 (redirect from GSK-3 inhibitor)
    shown that introducing competitive inhibitors of GSK-3 can increase glucose tolerance in diabetic mice. GSK-3 inhibitors may also have therapeutic effects...
    49 KB (5,773 words) - 16:32, 11 September 2024
  • MEK inhibitors in cancer therapy". Biochim Biophys Acta. 1773 (8): 1248–55. doi:10.1016/j.bbamcr.2006.11.009. PMID 17194493. "ASCO: MEK Inhibitors—Alone...
    6 KB (719 words) - 23:12, 12 May 2024
  • MTORC2 (redirect from MTOR Complex 2)
    mTOR Complex 2 (mTORC2) is an acutely rapamycin-insensitive protein complex formed by serine/threonine kinase mTOR that regulates cell proliferation and...
    34 KB (3,791 words) - 19:30, 19 September 2024
  • Thumbnail for Phosphoinositide 3-kinase
    isoform-specific inhibitors. As of January 2019, three PI3K inhibitors are approved by the FDA for routine clinical use in humans: the PIK3CD inhibitor idelalisib...
    32 KB (3,463 words) - 17:34, 20 November 2023
  • Hedgehog pathway inhibitors, also sometimes called hedgehog inhibitors, are small molecules that inhibit the activity of a component of the Hedgehog signaling...
    27 KB (3,866 words) - 12:49, 22 August 2024
  • Thumbnail for BRAF (gene)
    BRAF (gene) (redirect from Braf inhibitor)
    V600E is a determinant of sensitivity to proteasome inhibitors. Vulnerability to proteasome inhibitors is dependent on persistent BRAF signaling, because...
    48 KB (5,285 words) - 16:26, 21 August 2024
  • Thumbnail for Endometrial cancer
    inhibit the mTOR pathway may reduce the risk of disease worsening compared to having more chemotherapy or hormonal therapy. Though, mTOR inhibitors may...
    105 KB (10,821 words) - 12:23, 31 July 2024